Aytu BioPharma (AYTU) Scheduled to Post Earnings on Wednesday

Aytu BioPharma (NASDAQ:AYTU) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, November 13th.

Aytu BioPharma (NASDAQ:AYTU) last announced its earnings results on Thursday, September 26th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.45) by ($0.37). Aytu BioPharma had a negative net margin of 19.56% and a negative return on equity of 51.31%. The company had revenue of $17.98 million during the quarter.

Aytu BioPharma Price Performance

AYTU stock opened at $1.77 on Tuesday. The firm’s 50-day moving average is $2.28 and its two-hundred day moving average is $2.64. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.79 and a current ratio of 0.99. Aytu BioPharma has a 52 week low of $1.60 and a 52 week high of $3.45.

About Aytu BioPharma

Aytu Biopharma, Inc, a commercial-stage pharmaceutical company, focuses on commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company operates through two segments: Rx segment and Consumer Health segment. The Rx segment offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years and older, and Cotempla XR-ODT for patients from six to seventeen years old.